Premium
How cost‐effective is hepatitis C virus treatment for people who inject drugs?
Author(s) -
Martin Natasha K,
Vickerman Peter,
Miners Alec,
Hickman Matthew
Publication year - 2013
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/jgh.12113
Subject(s) - medicine , telaprevir , pegylated interferon , ribavirin , boceprevir , hepatitis c , hepatitis c virus , harm reduction , liver disease , cost effectiveness , alpha interferon , immunology , intensive care medicine , interferon , virus , risk analysis (engineering) , human immunodeficiency virus (hiv)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom